-The Indian Express In an article in these columns (‘A fertile mess', IE, December 11), Ashok Gulati says India has landed its fertiliser industry in a mess because of rising subsidies, lagging investment, unbalanced use of fertilisers and diversion of urea for other uses, among other things. He blames it all on administered pricing and subsidy costs, and advocates the increase of urea prices or cash transfer of the fertiliser subsidy...

-The Hindustan Times Despite paying as much as double the price, many health-conscious consumers who think they've gone organic really haven't. Information obtained by Crop Care Federation of India (CCFI) under the Right to Information Act proves that farms that claim to be organic regularly use chemical pesticides to protect their crops, yet market and sell their produce under the organic tag. Evidence of this practice came to light after information from...

-The Indian Express With the positive intent and progressive action from the new government, the country is excited about entering a new era of growth & revolutionary transformation. This can happen faster and more effectively if the whole ecosystem is geared for it. And most important component of the ecosystem are the people, who are the primary beneficiaries as well as the key catalysts to stimulate this growth and transformation. Hence,...

-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin...

-The Times of India NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'. The move is aimed at spanning the...